Modelled DT Structure
Method: loop building
Template PDB: 5OCH_A
Identity: 99.835%
Minimized Score: -1629.298 kcal/mol
Detail: Structure Info
General Information of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0054 | ||||
Gene Name | ABCB8 | ||||
Protein Name | ATP-binding cassette sub-family B member 8 | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
3D Structure |
Modelled DT Structure Method: loop building Template PDB: 5OCH_A Identity: 99.835% Minimized Score: -1629.298 kcal/mol Detail: Structure Info |
||||
Synonyms | ABCB8; EST328128; M-ABC1; MABC1; Mitochondrial ATP-binding cassette 1 | ||||
DT Family | ATP-Binding Cassette (ABC) Superfamily | ||||
Multidrug Resistance Exporter (MDR) Family (ABCB) | |||||
Tissue Specificity | Ubiquitous. | ||||
Function | This transporter is a complex, integral component of membrane, membrane, mitochondrial envelope, mitochondrion, nucleolus, nucleus, ATP binding, ATPase activity, coupled to transmembrane movement of substances, transporter activity. | ||||
Endogenous Substrate(s) | Peptides | ||||
Variability Data of This Drug Transporter (DT) | |||||
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
(β) Post-translational Modification of This DT |
|||||
(γ) Transcriptional Regulation of This DT |
|||||
(δ) Epigenetic Regulation of This DT |
|||||
(ε) Exogenous Modulation of This DT |
|||||
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
(β) Inter-species Structural Differences |
|||||
General Variability Data of This DT (VARIDT 1.0) |
|||||
(β) Disease-specific Protein Abundances of This DT |
|||||
(γ) Species- and Tissue-specific DT Abundances |
|||||
Molecular Transporting Profile of This DT | |||||
Full List of Drug(s) Transported by This DT |
|||||
Approved Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
Doxorubicin
|
Approved | Drug Info | Leukemia | 2A60-2B33 | [1] |
References | |||||
1 | ABCB8 mediates doxorubicin resistance in melanoma cells by protecting the mitochondrial genome. Mol Cancer Res. 2009 Jan;7(1):79-87. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.